Choosing the United States

Michael E. Porter; Jan W. Rivkin

Article | Harvard Business Review | March 2012

Choosing the United States

Abstract

The U.S. is not winning its appropriate share of location decisions, even those involving the high-value-adding activities that the country has long been able to attract. In part, this is because U.S. policy makers are not addressing weaknesses in the national business environment and are doing little to fight economic distortions that disfavor location in the United States. In addition, executives are prone to leave or overlook U.S. locations because they ignore many hidden costs associated with offshoring and do not consider how to enhance the economic potential of U.S. locations. Although both government and business must urgently address some unnecessary weaknesses in the U.S. business environment, there are hopeful signs that sophisticated management teams are reevaluating their rush offshore and, in some instances, are moving high-end mobile activities back to the United States.

Keywords: Decision Choices and Conditions; United States;

Format: Print

12 pages

Find at Harvard Purchase

Citation:

Porter, Michael E., and Jan W. Rivkin. "Choosing the United States." Harvard Business Review 90, no. 3 (March 2012): 80–91.

As the diffusion of value-based health care efforts accelerates globally, the need for interoperable information technology systems that support value-based care is essential. Such systems are needed to facilitate dramatic improvements in patient outcomes and efficiency and, importantly, to end an era in which health IT has entrenched the status quo, perpetuated silos, and blocked reimbursement reform. A value-enabling IT platform must organize data around conditions and must enable integrated practice units to integrate care both within and across health systems. In addition, the electronic health record should be the sole source of costing information so that accurate costs for every encounter can be tracked, aggregated, shared, and used for improvement. This is the next generation of health care IT.

Since its establishment in 2005, Hamburg’s Martini Klinik had single mindedly focused on prostate cancer care with a commitment to measure long-term health outcomes for every patient. A wholly owned subsidiary of the University Hospital Hamburg, Martini Klinik was a “hospital in a hospital” in close proximity to other medical departments and services. By 2019, Martini Klinik had become the largest prostate cancer treatment program in the world with 8,000 outpatient cases and more than 2,500 surgical cases annually. Patients came from all over Germany and from around the world. A new and expanded facility was under construction to have the capacity to manage more patients with prostate cancer.

Faculty & Research

Choosing the United States

Abstract

Citation:

About the Authors

More from these Authors